SEARCH

SEARCH BY CITATION

References

  • 1
    Bryan CS, Reynolds KL, Brenner ER. Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy. Rev Infect Dis 1983; 5: 629 38.
  • 2
    Weinstein MP, Murphy JR, Reller LB, Lichtenstein KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungaemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis 1983; 5: 54 70.
  • 3
    Ispahani P, Pearson NJ, Greenwood D. An analysis of community and hospital-acquired bacteraemia in a large teaching hospital in the United Kingdom. Q J Med 1987; 63: 427 40.
  • 4
    Haug JB, Harthug S, Kalager T, Digranes A, Solberg CO. Bloodstream infections at a Norwegian university hospital. 1974–79 and 1988–89: changing etiology, clinical features and outcome. Clin Infect Dis 1994; 19: 246 56.
  • 5
    Pittet D & Wenzel RP. Nosocomial bloodstream infections: secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 1995; 155: 1177 84.
  • 6
    Leibovici L, Samra Z, Konigsberger H, Drucker M, Ashkenazi S, Pitlik SD. Long-term survival following bacteremia or fungemia. JAMA 1995; 274: 807 12.
  • 7
    Jones GR & Lowes JA. The systemic inflammatory response syndrome as predictor of bacteraemia and outcome from sepsis. Q J Med 1996; 89: 515 22.
  • 8
    Pinner RW, Teutsch SM, Simonsen L, Klug LA, Graber JM, Clarke MJ, Berkelman RL. Trends in infectious diseases mortality in the United States. JAMA 1996; 275: 189 93.
  • 9
    Berman JR, Zaran FK, Rybak MJ. Pharmacy-based antimicrobial-monitoring service. Am J Hosp Pharm 1992; 49: 1701 6.
  • 10
    Pestotnik SL, Classen DC, Evans RS, Burke JP. Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med 1996; 124: 884 90.
  • 11
    Tomasz A. Multiple antibiotic resistant pathogenic bacteria. N Engl J Med 1994; 330: 1247 51.
  • 12
    Morris JG, Shay DK, Hebden JN, McCarter RJ, Perdue BE, Jarvis W et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med 1995; 123: 250 9.
  • 13
    Go ES, Urban C, Burns J, Kreiswirth B, Eisner W, Mariano N et al. Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet 1994; 344: 1329 32.
  • 14
    Meyers BR, Sherman E, Mendelson MH, Velasquez G, Srulevitch-Chin E, Hubbard M, Hirschman SZ. Bloodstream infections in the elderly. Am J Med 1989; 86: 379 84.
  • 15
    Gransden WR, Eykyn SJ, Phillips I, Rowe B. Bacteremia due to Escherichia coli. A study 861 episodes. Rev Infect Dis 1990; 12: 1008 18.
  • 16
    McCue JD. Improved mortality in gram-negative bacillary bacteremia. Arch Intern Med 1985; 145: 1212 6.
  • 17
    Watanakunakorn C & Jura J. Klebsiella bacteremia: a review of 196 episodes during a decade (1980–89). Scand J Infect Dis 1991; 23: 399 405.
  • 18
    Leibovici L, Konigsberger H, Pitlik SD, Samra Z, Drucker M. Patients at risk for inappropriate antibiotic treatment of bacteremia. J Intern Med 1992; 231: 371 4.
  • European Organization for Research and Treatment of Cancer (EORTC), International Antimicrobial Therapy Cooperative Group, and the National Cancer Institute of Canada – Clinical Trials Group. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients.
    J Infect Dis 1991; 163: 951–8.
  • 20
    Phillips I. Resistance as a cause of treatment failure. J Antimicrob Chemother 1986; 18 (Suppl. C): 255 60.